Renal arteriovenous malformations (rAVMs) are rare, occurring abnormality of the renal vasculature. On a global scale, its prevalence is only 0.04% [1]. Renal AVMs are composed of dilated, enlarged, tortuous vessels which are formed by abnormal communications between renal arteries and veins forming a complex nidus. These connections are devoid of an intervening capillary network, resulting in shunting flow of high pressure arterial blood to low pressure venous blood. Renal AVMs can be categorized into congenital, idiopathic, and acquired types. Of the three, acquired renal AVMS are found to be the most commonly occurring, making up about 70% - 80% of all renal AVMs [2]. On the contrary, idiopathic renal AVMs are the least common and are typically discovered incidentally during imaging, with their etiology remaining unclear. Based on previous reports, individuals in the middle age group are found to be more prone to develop renal AVMS. Furthermore, studies have shown a favourable female gender predisposition [3]. Various theories have been proposed regarding their development. Renal AVMs can pose a diagnostic challenge, due to its diverse clinical presentation. Some patients are completely asymptomatic upon diagnosis. However, others may exhibit worrying symptoms such as hematuria, flank pain, or a palpable mass. Severe cases may present with renal failure or life-threatening torrential hemorrhage. Diagnosis often involves a combination of imaging techniques including Doppler ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) to visualize the intricate vascular structures and determine the extent of the malformation. This case series illustrates an overview of a range of cases that focuses on the clinical presentations, racial and demographic factors that could influence the prevalence of Renal AVMs in East Malaysia, as well as their diagnostic approaches, and management strategies.

This retrospective case series was conducted between January 2020 and December 2024 at Queen Elizabeth Hospital, a tertiary referral centre in Kota Kinabalu, Sabah, East Malaysia. The case series comprised 3 cases of incidental renal arteriovenous malformations (rAVMs) managed with endovascular embolization. Inclusion criteria comprised adult patients with confirmed rAVM on CTA (computer tomographic Angiography) or digital subtraction angiography (DSA) regardless of variation of symptoms.

The cases were compared on several factors including, age, gender, race, co morbids, and clinical presentation. Table 1 depicts the demographic distribution and comparison of clinical presentations between the 3 cases.

Table 1. Patient demographic distribution and clinical symptoms.

Cases with incomplete imaging data or non-renal AVMs were excluded. Clinical data, radiological findings, treatment modalities, and outcomes—including renal function before and after embolization—were collected and tabulated to establish comparisons and similarities between the cases. The findings have been illustrated systematically as shown in Table 2.

Table 2. Summary of procedural elements and embolization outcomes.

Post embolization, all 3 patients had regular renal function blood tests to monitor renal function. In all 3 patients, serum creatinine and EGFR remained stable post procedure. Table 3 depicts the renal profiles of the 3 cases during the pre and post embolization period.

Table 3. Blood parameter trends and evaluation of pre and post embolization renal function.

For each case, the Renal AVM nidus identified was classified in reference to Yakes classification of Renal AVMs as shown in Table 4.

Table 4. Yakes classification for renal AVM.

Renal Arteriovenous malformation is considered an uncommon pathology in the human population. With a prevalence of only 0.04%, it is very often underdiagnosed or misdiagnosed [1]. Renal AVMs by definition are a configuration of abnormal connections between renal arteries and veins that are devoid of an intermediating capillary bed. The result of these connections is the formation of a vascular nidus which appears as composition of dilated and tortuous vessels [2]. In terms of risk factors, Gender predisposition plays an important factor as rAVMs tend to affect females twice as much than men. In our case series, we can see gender predispostition as a favourable factor for renal AVMs as all our patients in this case series are females. However, contrary to the reported peak incidence age group of renal AVMs which is usually during the 3rd decade of life, all the patients reported in this case series were ranging between 50 - 70 years old at the time of diagnosis [3].

Renal AVMs can be divided into congenital, acquired and idiopathic renal AVMs. Of the three, acquired renal AVMs are the most common making up 70% - 80% of all renal AVMs. They usually manifest as arteriovenous fistulas occurring as a result of iatrogenic injuries such as renal biopsies, penetrating or blunt trauma, or renal malignancy or inflammation [4]. The congenital type representing about 25% of renal AVMS, usually occur during 4th to 10th week of intrauterine fetal development due to failures in focal spontaneous vascular development. This type of AVM usually only becomes symptomatic during the 3rd and 4th decades of life [5].

Idiopathic aneurysms though are the rarest form renal AVMs, comprising of only 5% of all renal avms cases [6]. True to its terminology, idiopathic renal avms have no identifiable cause. In this case series, we identified a growing prevalence of Renal AMVS in East Malaysia, particularly the state of Sabah. Previous literature describes that most cases of rAVMs are found to be occurring in the left kidney, more commonly involving the upper pole, but can occur in mid pole and lower pole as well in equal proportions. Moreover, they predominantly occur in the renal parenchyma rather than the collecting system [7].

Renal AVMs can present in a wide range of clinical scenarios, from asymptomatic instances to severe symptoms like hematuria, flank pain, perinephric hematoma, abdominal mass, abdominal bruit, hypertension, and in severe cases, renal failure or life-threatening hemorrhage. Hematuria is a common symptom of renal AVMs, but ironically renal AVMs are not a common cause of hematuria. This is clinically evident in the cases reported, in which the majority of them presented with a main complaint of hematuria. On a histological level, the absence of the elastic lamina beneath the renal calyx or renal pelvis mucosa makes the vessels fragile and more prone to damage. Increased vascular pressure causing rupture of these dysplastic subepithelial vessels explains the pathogenesis for the development of hematuria in renal AVMS [8]-[10]. This occurs in response to increased vascular pressure as high-pressure arterial blood is directly shunted into low-pressure veins causing blood to enter the collecting system. In cases where hematuria is severe, blood clots may form, and may result in blockage of the renal pelvis and ureters. As a result, the patient may develop flank pain and abdominal pain which was also evident in some of the cases discussed in this case series [11].

The growing prevalence of renal avms in east malaysia, raises the concerns to determine the potential causes or risk factors in hopes of finding a common causative link for predisposition. In this study, we observed that all patients were female, aged between 50 and 72 years, which is well established as known risk factors favouring renal AVMS. Another similarity we found was that all 3 patients were of Kadazan-Dusun ethnicity. While this may suggest a potential demographic clustering, we emphasize that such findings are hypothesis-generating and limited by the small sample size. Statistical inference regarding racial predisposition cannot be drawn from this limited case series.

The molecular mechanisms for the pathogenesis renal arteriovenous malformation (rAVM) formation aren’t completely understood, but emerging evidence implicates genetic and angiogenic dysregulation similar to that described in hereditary vascular disorders such as hereditary hemorrhagic telangiectasia (HHT) and capillary malformation–arteriovenous malformation (CM-AVM) syndrome [12]. Mutations in genes such as ENG (endoglin) and ACVRL1 (ALK-1), both key regulators of the transforming growth factor-β (TGF-β) signaling pathway, result in endothelial dysfunction and aberrant vascular remodeling. Some studies suggest that the loss of endothelial endoglin function, and the role vascular endothelial growth factor (VEGF) as an angiogenic stimuli may promote direct arteriovenous shunting [13].

As of now, not much of molecular studies has been done on Renal AVM, however most of these mechanisms are already well established in cerebral and systemic AVMs. Therefore, it is plausible that renal AVMs share a similar pathophysiological basis. Somatic mutations involving the RAS-MAPK signaling pathway (including KRAS and MAP2K1) have also been reported in sporadic AVMs, promoting endothelial proliferation and vessel wall instability [14][15]. Further molecular characterization of renal AVMs is therefore warranted to determine whether comparable genetic or angiogenic mechanisms contribute to their formation [16].

Moreover, the formation of AVM can be attributed to blood flow and shear stress on the vasculature. Studies have shown that under normal circumstances, healthy Endothelial cells (EC) migrate against the direction of blood flow which helps to maintain normal vasculature. However, in cases where there is loss of endoglin, ECs become dysfunctional and tend to migrate in the direction of blood flow. This inevitably leads to accumulation of ECs on the venous side of capillaries, thus supporting the notion that the formation of AVMs in Hereditary hemorrhagic telengectasia might originate at the venous side [17]. The histological appearance of arteriovenous malformations (AVMs) consists of tortuous arteries, irregular in caliber, with fragmented and thickened elastic laminae. Conversely, the veins commonly exhibit intimal hyperplasia, thickening of the perivascular smooth muscle, and adventitial fibrosis as a result of the high-pressure, turbulent arterial flow [18]. Therefore, it could be postulated that the pathogenesis of renal avms could develop as a result of endothelial dysfunction and overactivation of pro angiogenic pathways,

Diagnosing Renal Avms can be challenging task. Therefore, the initial workup usually focuses on ruling out associated pathologies such as urological malignancies and renal colics. In the event these pathologies have been excluded, a targeted vascular imaging would be warranted. The main modalities of establishing a diagnosis is via a computed tomography (CT) angiogram or digital subtraction angiography (DSA) [19].

Emergency management for rAVM includes surgery or transcatheter renal artery embolization (RAE). RAE has become the preferred treatment option due to the advancements in endovascular embolization [20]. Its advantages include less invasiveness, greater effectiveness, avoidance of general anesthesia, shorter hospital stays [21], reduced perioperative and postoperative morbidity, and preservation of unaffected renal parenchyma. Despite these benefits, potential risks remain, such as renal infarction, pulmonary embolism, recanalization, and incomplete occlusion. Successful embolization aims for the total occlusion of the malformed or shunted vessels while preserving normal renal arterial branches and preventing embolic material migration or reflux. Recent studies have demonstrated high technical success and long-term safety of embolization for renal AVMs, with minimal impact on renal function [22]. Our findings are consistent with these reports, as none of the patients in this series experienced post-procedural renal impairment.

In the event of failed embolisation or ruptured AVMs which render the patient hemodynamically unstable, Surgical intervention may be the only alternative of treatment. A total or partial nephrectomy would be warranted to achieve optimal patient outcome. Renal artery ligation can also be considered an option although these are less favorable options as they are more invasive, require longer hospital stays, involve slower recovery, carry higher morbidity due to the risk of complete loss of renal function, involve complications from general anesthesia, and carry postoperative complications [23]. Nonetheless, surgery remains a treatment option in life-threatening conditions where embolization has failed or is technically difficult. The choice of embolic agents depends on the type of rAVM, the cause (traumatic vs. non-traumatic), and the angioarchitecture of the malformed vessels (flow, feeder, size of the fistula, and accessibility to the target lesion).

The rare presentation of renal AVMs amongst patients particularly in East Malaysia, Sabah highlights a need for further epidemiological investigation. While demographic or racial predisposition may be suspected, these observations should be viewed as exploratory and not conclusive due to the limited sample size. The non-specific symptoms of this disease make it a diagnostic challenge for clinicians. Prompt recognition of rAVM as a differential diagnosis for unexplained hematuria is essential, as delayed diagnosis may risk rupture and torrential hemorrhage. Endovascular embolization remains the gold standard treatment for renal AVMs. Selection of embolic agents should be tailored to the lesion’s angioarchitecture to minimize recurrence. Long-term follow-up is recommended to ensure sustained vessel occlusion and preservation of renal function. Finally, given the complexity of this disease, a multidisciplinary approach involving a urologist, radiologist, and interventional radiologist is crucial to achieve optimal patient outcomes.